This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jun 23, 2026
A study from the University of Chicago made 12 people with type 1 diabetes insulin-independent, but a cure for the masses is still a long way off.
Jun 10, 2026
Patient 9 of the Eledon trial, who received an islet cell transplant, talks about life after being "cured" of type 1 diabetes and the work still left to be done.
Apr 28, 2026
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 17, 2026
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
Feb 12, 2026
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Nov 10, 2025
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
